Abstract
This chapter reviews medication issues, treatments, and therapies for people with intellectual disabilities. Also considered are how commonly concurrent medical issues and their treatments may influence the functioning and development of persons with intellectual disabilities. The spectrum of available treatments from the most widely used to novel and experimental and the research support for each treatment is critically reviewed. Evidence is also weighed concerning unproved and complementary and alternative treatments.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler, K., Reghunathan, A., Hutchison, L. H., & Kalpatthi, R. (2016). Dural Venous Sinus Diameters in children with sickle cell disease: Correlation with history of stroke in a case-control study. Southern Medical Journal, 109(9), 511–515. https://doi.org/10.14423/SMJ.0000000000000513
Alexander, R. C. (2016). Prader-Willi syndrome. In I. L. Rubin, J. Merrick, D. E. Greydanus, & D. R. Patel (Eds.), Health care for people with intellectual and developmental disabilities across the lifespan (pp. 779–798). Cham, Switzerland: Springer. https://doi.org/10.1007/978-3-319-18096-0_66
Allen, D., Langthorne, P., Tonge, B., Emerson, E., McGill, P., Fletcher, R., … Kennedy, C. (2013). Towards the prevention of behavioural and psychiatric disorders in people with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 26(6), 501–514. https://doi.org/10.1111/jar.12050
Barnard-Brak, L., Davis, T. N., Schmidt, M., & Richman, D. M. (2016). Effects associated with on- and off-label stimulant treatment of core autism and ADHD symptoms exhibited by children with autism spectrum disorder. Developmental Neurorehabilitation, 19(1), 46–53. https://doi.org/10.3109/17518423.2014.904949
Barnett, J. E. H., & O’Shaughnessy, K. (2015). Enhancing collaboration between occupational therapists and early childhood educators working with children on the autism spectrum. Early Childhood Education Journal, 43(6), 467–472. https://doi.org/10.1007/s10643-015-0689-2
Barton, E. E., Reichow, B., Schnitz, A., Smith, I. C., & Sherlock, D. (2015). A systematic review of sensory-based treatments for children with disabilities. Research in Developmental Disabilities, 37, 64–80. https://doi.org/10.1016/j.ridd.2014.11.006
Basil, J. S., Santoro, S. L., Martin, L. J., Healy, K. W., Chini, B. A., & Saal, H. M. (2016). Retrospective study of obesity in children with Down Syndrome. The Journal of Pediatrics, 173, 143–148. https://doi.org/10.1016/j.jpeds.2016.02.046
Brown, M., Jacobstein, D., Yoon, I. S., Anthony, B., & Bullock, K. (2016). System-wide initiative documents robust health screening for adults with intellectual disability. Intellectual and Developmental Disabilities, 54(5), 354–365. https://doi.org/10.1352/1934-9556-54.5.354
Carlino, E., Piedimonte, A., & Benedetti, F. (2016). Nature of the placebo and nocebo effect in relation to functional neurologic disorders. Handbook of Clinical Neurology, 139, 597–606. https://doi.org/10.1016/B978-0-12-801772-2.00048-5
Case-Smith, J., Weaver, L. L., & Fristad, M. A. (2015). A systematic review of sensory processing interventions for children with autism spectrum disorders. Autism, 19(2), 133–148. https://doi.org/10.1177/1362361313517762
Charlot, L., Abend, S., Ravin, P., Mastis, K., Hunt, A., & Deutsch, C. (2011). Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities. Journal of Intellectual Disability Research, 55(2), 199–209. https://doi.org/10.1111/j.1365-2788.2010.01294.x
Cohen, D., Raffin, M., Canitano, R., Bodeau, N., Bonnot, O., Périsse, D., … Laurent, C. (2013). Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects. Research in Autism Spectrum Disorders, 7(1), 167–175. https://doi.org/10.1016/j.rasd.2012.08.001
Craft, S., Baker, L. D., Montine, T. J., Minoshima, S., Watson, G. S., Claxton, A., … Gerton, B. (2012). Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Archives of Neurology, 69(1), 29–38. https://doi.org/10.1001/archneurol.2011.233
Crnic, K. A., Neece, C. L., McIntyre, L. L., Blacher, J., & Baker, B. L. (2017). Intellectual disability and developmental risk: Promoting intervention to improve child and family well-being. Child Development, 88(2), 436–445. https://doi.org/10.1111/cdev.12740
Dagnan, D., Masson, J., Cavagin, A., Thwaites, R., & Hatton, C. (2015). The development of a measure of confidence in delivering therapy to people with intellectual disabilities. Clinical Psychology & Psychotherapy, 22(5), 392–398. https://doi.org/10.1002/cpp.1898
de Kuijper, G., Evenhuis, H., Minderaa, R. B., & Hoekstra, P. J. (2014). Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. Journal of Intellectual Disability Research, 58(1), 71–83. https://doi.org/10.1111/j.1365-2788.2012.01631.x
Deb, S., Chaplin, R., Sohanpal, S., Unwin, G., Soni, R., & Lenotre, L. (2008). The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: A systematic review. Journal of Intellectual Disability Research, 52(2), 107–113. https://doi.org/10.1111/j.1365-2788.2007.00965.x
Deb, S., Farmah, B. K., Arshad, E., Deb, T., Roy, M., & Unwin, G. L. (2014). The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder – A systematic review. Research in Developmental Disabilities, 35(3), 711–725. https://doi.org/10.1016/j.ridd.2013.12.004
Dijkhuizen, A., Hilgenkamp, T. I. M., Krijnen, W. P., van der Schans, C. P., & Waninge, A. (2016). The impact of visual impairment on the ability to perform activities of daily living for persons with severe/profound intellectual disability. Research in Developmental Disabilities, 48, 35–42. https://doi.org/10.1016/j.ridd.2015.10.001
Ding, H. T., Taur, Y., & Walkup, J. T. (2017). Gut microbiota and autism: Key concepts and findings. Journal of Autism and Developmental Disorders, 47(2), 480–489. https://doi.org/10.1007/s10803-016-2960-9
Dolce Filho, R. (2006). Homeopathic approach in the treatment of patients with mental disability. Homeopathy: The Journal of the Faculty of Homeopathy, 95(1), 31–44. https://doi.org/10.1016/j.homp.2005.10.001
Dunn, K., Hughes-McCormack, L., & Cooper, S.-A. (2017). Hospital admissions for physical health conditions for people with intellectual disabilities: Systematic review. Journal of Applied Research in Intellectual Disabilities, 31(Suppl 1), 1–10. https://doi.org/10.1111/jar.12360
Edelsohn, G. A., Schuster, J. M., Castelnovo, K., Terhorst, L., & Parthasarathy, M. (2014). Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders. Psychiatric Services, 65(2), 201–207. https://doi.org/10.1176/appi.ps.201300029
Erickson, S. R., Spoutz, P., Dorsch, M., & Bleske, B. (2016). Cardiovascular risk and treatment for adults with intellectual or developmental disabilities. International Journal of Cardiology, 221, 371–375. https://doi.org/10.1016/j.ijcard.2016.07.044
Foxx, R. M., & Mulick, J. A. (2015). Controversial therapies for autism and intellectual disabilities: Fad, fashion, and science in professional practice. New York, NY: Routledge.
Glanzman, M. M., & Toomey, M. (2016). Complementary and alternative therapies. In N. N. Singh (Ed.), Handbook of evidence-based practices in intellectual and developmental disabilities (pp. 243–282). Cham, Switzerland: Springer.
Greydanus, D. E., & Merrick, J. (2016). Smith-magenis syndrome. In I. L. Rubin, J. Merrick, D. E. Greydanus, & D. R. Patel (Eds.), Health care for people with intellectual and developmental disabilities across the lifespan (pp. 821–825). Cham, Switzerland: Springer. https://doi.org/10.1007/978-3-319-18096-0_69
Grieco, J. C., Ciarlone, S. L., Gieron-Korthals, M., Schoenberg, M. R., Smith, A. G., Philpot, R. M., … Weeber, E. J. (2014). An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome. BMC Neurology, 14(1), 232. https://doi.org/10.1186/s12883-014-0232-x
Häβler, F., Thome, J., & Reis, O. (2014). Polypharmacy in the treatment of subjects with intellectual disability. Journal of Neural Transmission, 122(Suppl. 1), S93–S100. https://doi.org/10.1007/s00702-014-1219-x
Harner, I. C., & Foiles, R. A. (1980). Effect of Feingold’s K-P diet on a residential mentally handicapped population. Journal of the American Dietetic Association, 76(6), 575–578.
Heller, T., McCubbin, J. A., Drum, C., & Peterson, J. (2011). Physical activity and nutrition health promotion interventions: What is working for people with intellectual disabilities? Intellectual and Developmental Disabilities, 49(1), 26–36. https://doi.org/10.1352/1934-9556-49.1.26
Hodapp, R. M., & Dykens, E. M. (2012). Genetic disorders of intellectual disability: Expanding our concepts of phenotypes and of family outcomes. Journal of Genetic Counseling, 21(6), 761–769. https://doi.org/10.1007/s10897-012-9536-4
Hooking, J., McNeil, J., & Campbell, J. (2016). Physical therapy interventions for gross motor skills in people with an intellectual disability aged 6 years and over: A systematic review. International Journal of Evidence-Based Healthcare, 14, 166–174.
Huguet, A., Olthuis, J., McGrath, P., Tougas, M., Hayden, J., Stinson, J., & Chambers, C. (2017). Systematic review of childhood and adolescent risk and prognostic factors for persistent abdominal pain. Acta Paediatrica, 106(4), 545–553. https://doi.org/10.1111/apa.13736
Hyman, S. L., Stewart, P. A., Foley, J., Cain, U., Peck, R., Morris, D. D., … Smith, T. (2016). The gluten-free/casein-free diet: A double-blind challenge trial in children with autism. Journal of Autism and Developmental Disorders, 46(1), 205–220. https://doi.org/10.1007/s10803-015-2564-9
Jeng, S.-C., Chang, C.-W., Liu, W.-Y., Hou, Y.-J., & Lin, Y.-H. (2017). Exercise training on skill-related physical fitness in adolescents with intellectual disability: A systematic review and meta-analysis. Disability and Health Journal, 10(2), 198–206. https://doi.org/10.1016/j.dhjo.2016.12.003
Kahn, J., Koh, A., Luckcuck, R., McNeice, J., Walter, E., Yao, W., … Link, T. (2016). A phenylalanine fiasco: The structure of phenylalanine hydroxylase and its impact on phenylketonuria. The FASEB Journal, 30(1 Suppl), 665.8–665.8.
Kaptchuk, T. J., & Miller, F. G. (2015). Placebo effects in medicine. New England Journal of Medicine, 373(1), 8–9. https://doi.org/10.1056/NEJMp1504023
Koch, G., Poulsen, S., Espelid, I., & Haubek, D. (2016). Pediatric dentistry: A clinical approach. London, England: Wiley.
Koegel, L. K., Krasno, A. M., Taras, H., Koegel, R. L., & Frea, W. (2013). Is medication information for children with autism spectrum disorder monitored and coordinated across professionals? Findings from a teacher survey. School Mental Health, 5(1), 48–57. https://doi.org/10.1007/s12310-012-9098-5
Koslowski, N., Klein, K., Arnold, K., Kösters, M., Schützwohl, M., Salize, H. J., & Puschner, B. (2016). Effectiveness of interventions for adults with mild to moderate intellectual disabilities and mental health problems: Systematic review and meta-analysis. The British Journal of Psychiatry, 209(6), 469–474. https://doi.org/10.1192/bjp.bp.114.162313
Kurtz, P. F., Boelter, E. W., Jarmolowicz, D. P., Chin, M. D., & Hagopian, L. P. (2011). An analysis of functional communication training as an empirically supported treatment for problem behavior displayed by individuals with intellectual disabilities. Research in Developmental Disabilities, 32(6), 2935–2942. https://doi.org/10.1016/j.ridd.2011.05.009
Lake, J. K., Vogan, V., Sawyer, A., Weiss, J. A., & Lunsky, Y. (2015). Psychotropic medication use among adolescents and young adults with an autism spectrum disorder: Parent views about medication use and healthcare services. Journal of Child and Adolescent Psychopharmacology, 25(3), 260–268. https://doi.org/10.1089/cap.2014.0106
Lance, E. I., & Shapiro, B. K. (2013). Confounding diagnoses in the neurodevelopmental disabilities population a child with hearing loss, absence epilepsy, and attention-deficit hyperactivity disorder (ADHD). Journal of Child Neurology, 28(5), 645–647. https://doi.org/10.1177/0883073812447980
Liao, H.-H., Yen, H.-R., Muo, C.-H., Lee, Y.-C., Wu, M.-Y., Chou, L.-W., … Chang, T.-T. (2017). Complementary traditional Chinese medicine use in children with cerebral palsy: A nationwide retrospective cohort study in Taiwan. BMC Complementary and Alternative Medicine, 17, 155. https://doi.org/10.1186/s12906-017-1668-5
Ly, V., Bottelier, M., Hoekstra, P. J., Vasquez, A. A., Buitelaar, J. K., & Rommelse, N. N. (2017). Elimination diets’ efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder. European Child & Adolescent Psychiatry, 26(9), 1067–1079. https://doi.org/10.1007/s00787-017-0959-1
Martin, G. E., Lee, M., & Losh, M. (2017). Intellectual disability. In L. Cummings (Ed.), Research in clinical pragmatics (pp. 109–129). Cham, Switzerland: Springer. https://doi.org/10.1007/978-3-319-47489-2_5
Mazahery, H., Conlon, C., Beck, K. L., Kruger, M. C., Stonehouse, W., Camargo, C. A., … von Hurst, P. R. (2016). Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: A study protocol for a factorial randomised, double-blind, placebo-controlled trial. Trials, 17, 295. https://doi.org/10.1186/s13063-016-1428-8
McPaul, A., Walker, B., Law, J., & McKenzie, K. (2016). An exploratory study investigating how adults with intellectual disabilities perform on the Visual Association Test (VAT). Journal of Applied Research in Intellectual Disabilities, 30(5), 824–829. https://doi.org/10.1111/jar.12273
Moses, L., Katz, N., & Weizman, A. (2014). Metabolic profiles in adults with autism spectrum disorder and intellectual disabilities. European Psychiatry, 29(7), 397–401. https://doi.org/10.1016/j.eurpsy.2013.05.005
Mula, M. (2016). Using anxiolytics in epilepsy: Neurobiological, neuropharmacological and clinical aspects. Epileptic Disorders, 18(3), 217–227. https://doi.org/10.1684/epd.2016.0837
Norderyd, J., Klingberg, G., Faulks, D., & Granlund, M. (2016). Specialised dental care for children with complex disabilities focusing on child’s functioning and need for general anaesthesia. Disability and Rehabilitation, 39(24), 2484–2491. https://doi.org/10.1080/09638288.2016.1236406
Novak, I. (2014). Evidence-based diagnosis, health care, and rehabilitation for children with cerebral palsy. Journal of Child Neurology, 29(8), 1141–1156. https://doi.org/10.1177/0883073814535503
Ouellette-Kuntz, H. (2005). Understanding health disparities and inequities faced by individuals with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 18(2), 113–121. https://doi.org/10.1111/j.1468-3148.2005.00240.x
Persch, A. C., Lamb, A. J., Metzler, C. A., & Fristad, M. A. (2015). Healthy habits for children: Leveraging existing evidence to demonstrate value. American Journal of Occupational Therapy, 69(4), 6904090010p1–6904090010p5. https://doi.org/10.5014/ajot.2015.694001
Posar, A., & Visconti, P. (2016). Complementary and alternative medicine in autism: The question of omega-3. Pediatric Annals, 45(3), e103–e107. https://doi.org/10.3928/00904481-20160129-01
Prasher, V. P. (2004). Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer’s disease in adults with Down syndrome: Implications for the intellectual disability population. International Journal of Geriatric Psychiatry, 19(6), 509–515. https://doi.org/10.1002/gps.1077
Ptomey, L., Goetz, J., Lee, J., Donnelly, J., & Sullivan, D. (2013). Diet quality of overweight and obese adults with intellectual and developmental disabilities as measured by the healthy eating index-2005. Journal of Developmental and Physical Disabilities, 25(6), 625–636. https://doi.org/10.1007/s10882-013-9339-z
Robertson, J., Emerson, E., Gregory, N., Hatton, C., Turner, S., Kessissoglou, S., & Hallam, A. (2000). Lifestyle related risk factors for poor health in residential settings for people with intellectual disabilities. Research in Developmental Disabilities, 21(6), 469–486. https://doi.org/10.1016/S0891-4222(00)00053-6
Robinson, S. J. (2012). Childhood epilepsy and autism spectrum disorders: Psychiatric problems, phenotypic expression, and anticonvulsants. Neuropsychology Review, 22(3), 271–279. https://doi.org/10.1007/s11065-012-9212-3
Ruud, M. P., Raanaas, R. K., & Bjelland, M. (2016). Caregivers’ perception of factors associated with a healthy diet among people with intellectual disability living in community residences: A concept mapping method. Research in Developmental Disabilities, 59, 202–210. https://doi.org/10.1016/j.ridd.2016.09.006
Salameh, T. S., Bullock, K. M., Hujoel, I. A., Niehoff, M. L., Wolden-Hanson, T., Kim, J., … Banks, W. A. (2015). Central nervous system delivery of intranasal insulin: Mechanisms of uptake and effects on cognition. Journal of Alzheimer’s Disease, 47(3), 715–728. https://doi.org/10.3233/JAD-150307
Sarasua, S. M., Dwivedi, A., Boccuto, L., Chen, C.-F., Sharp, J. L., Rollins, J. D., … DuPont, B. R. (2014). 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome. Genetics in Medicine, 16(4), 318–328. https://doi.org/10.1038/gim.2013.144
Sawyer, A., Lake, J. K., Lunsky, Y., Liu, S.-K., & Desarkar, P. (2014). Psychopharmacological treatment of challenging behaviours in adults with autism and intellectual disabilities: A systematic review. Research in Autism Spectrum Disorders, 8(7), 803–813. https://doi.org/10.1016/j.rasd.2014.03.021
Schoenbrodt, L., Kumin, L., Dautzenberg, D., & Lynds, J. (2016). Training parents to enhance narrative language skills in their children with intellectual disability. International Medical Review on Down Syndrome, 20(3), 31–38. https://doi.org/10.1016/j.sdeng.2016.09.001
Scott, H. M., & Havercamp, S. M. (2016). Systematic review of health promotion programs focused on behavioral changes for people with intellectual disability. Intellectual and Developmental Disabilities, 54(1), 63–76. https://doi.org/10.1352/1934-9556-54.1.63
Segal, M., Eliasziw, M., Phillips, S., Bandini, L., Curtin, C., Kral, T. V. E., … Must, A. (2016). Intellectual disability is associated with increased risk for obesity in a nationally representative sample of U. S. children. Disability and Health Journal, 9(3), 392–398. https://doi.org/10.1016/j.dhjo.2015.12.003
Sharma, A., & Shaw, S. R. (2012). Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: A meta-analysis. Journal of Pediatric Health Care, 26(4), 291–299. https://doi.org/10.1016/j.pedhc.2011.02.008
Shen, J., & Morton, C. C. (2016). Next-generation newborn hearing screening. Monographs in Human Genetics, 20, 30–39. https://doi.org/10.1159/000444598
Shin, J.-Y., Roughead, E. E., Park, B.-J., & Pratt, N. L. (2016). Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): Nationwide self-controlled case series study. BMJ, 353, i2550. https://doi.org/10.1136/bmj.i2550
Simonoff, E., Taylor, E., Baird, G., Bernard, S., Chadwick, O., Liang, H., … Jichi, F. (2013). Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. Journal of Child Psychology and Psychiatry, 54(5), 527–535. https://doi.org/10.1111/j.1469-7610.2012.02569.x
Travers, J. C. (2017). Evaluating claims to avoid pseudoscientific and unproven practices in special education. Intervention in School and Clinic, 52(4), 195–203. https://doi.org/10.1177/1053451216659466
Travers, J. C., Ayers, K., Simpson, R. L., & Crutchfield, S. (2016). Fad, pseudoscientific, and controversial interventions. In R. Lang, T. B. Hancock, & N. N. Singh (Eds.), Early intervention for young children with autism spectrum disorder (pp. 257–293). Cham, Switzerland: Springer.
van Karnebeek, C. D. M., Stockler-Ipsiroglu, S., Jaggumantri, S., Assmann, B., Baxter, P., Buhas, D., … Hartmann, H. (2014). Lysine-restricted diet as adjunct therapy for pyridoxine-dependent epilepsy: The PDE consortium consensus recommendations. In J. Zschocke, K. M. Gibson, G. Brown, E. Morava, & V. Peters (Eds.), JIMD reports (Vol. 15, pp. 47–57). Berlin Heidelberg: Springer. Retrieved from http://link.springer.com/chapter/10.1007/8904_2014_296
van Ool, J. S., Snoeijen-Schouwenaars, F. M., Schelhaas, H. J., Tan, I. Y., Aldenkamp, A. P., & Hendriksen, J. G. M. (2016). A systematic review of neuropsychiatric comorbidities in patients with both epilepsy and intellectual disability. Epilepsy & Behavior, 60, 130–137. https://doi.org/10.1016/j.yebeh.2016.04.018
van Schrojenstein Lantman-de Valk, H. M., & Walsh, P. N. (2008). Managing health problems in people with intellectual disabilities. BMJ, 337, a2507. https://doi.org/10.1136/bmj.a2507
van Timmeren, E. A., van der Putten, A. a. J., van Schrojenstein Lantman-de Valk, H. M. J., van der Schans, C. P., & Waninge, A. (2016). Prevalence of reported physical health problems in people with severe or profound intellectual and motor disabilities: A cross-sectional study of medical records and care plans. Journal of Intellectual Disability Research, 60(11), 1109–1118. https://doi.org/10.1111/jir.12298
Walsh, D., Belton, S., Meegan, S., Bowers, K., Corby, D., Staines, A., … Sweeney, M. R. (2017). A comparison of physical activity, physical fitness levels, BMI and blood pressure of adults with intellectual disability, who do and do not take part in Special Olympics Ireland programmes: Results from the SOPHIE study. Journal of Intellectual Disabilities, 22(2), 154–170. https://doi.org/10.1177/1744629516688773
Weise, J., Pollack, A., Britt, H., & Trollor, J. N. (2016). Primary health care for people with an intellectual disability: An exploration of demographic characteristics and reasons for encounters from the BEACH programme. Journal of Intellectual Disability Research, 60(11), 1119–1127. https://doi.org/10.1111/jir.12301
Weisman, O., Guri, Y., Gur, R. E., McDonald-McGinn, D. M., Calkins, M. E., Tang, S. X., … Gothelf, D. (2017). Subthreshold psychosis in 22q11.2 deletion syndrome: Multisite naturalistic study. Schizophrenia Bulletin, 43(5), 1079–1089. https://doi.org/10.1093/schbul/sbx005
Williams, K. E., Seiverling, L. J., & Field, D. G. (2014). Feeding problems. In P. Sturmey & R. Didden (Eds.), Evidence-based practice and intellectual disabilities (pp. 198–218). London, England: Wiley.
Zwanenburg, R. J., Bocca, G., Ruiter, S. A. J., Dillingh, J. H., Flapper, B. C. T., van den Heuvel, E. R., & van Ravenswaaij-Arts, C. M. A. (2016). Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial. European Journal of Human Genetics, 24(12), 1696–1701. https://doi.org/10.1038/ejhg.2016.109
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shaw, S.R., Jankowska, A.M. (2018). Medical Issues, Therapies, and Treatments. In: Pediatric Intellectual Disabilities at School. Pediatric School Psychology. Springer, Cham. https://doi.org/10.1007/978-3-030-02992-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-02992-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-02990-6
Online ISBN: 978-3-030-02992-0
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)